Found 11 matching trials
Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
PHASE2A three sequence, open-label, multi-center, prospective, study in stable ki...
Location
University of Cincinnati
LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
PHASE2An open-label, multi-center, prospective, randomized study to evaluate the ...
Location
Mayo Clinic - Phoenix
Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
PHASE3This study will evaluate the efficacy and safety of LCP-Tacro (tacrolimus) ...
Location
Clinical Site 1020
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
PHASE4The investigators believe that the pharmacological properties of Envarsus®,...
Location
Nantes University Hospital
Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant
PHASE2The purpose of this study is to evaluate the pharmacokinetics of LCP-Tacro ...
Location
Clinical Investigative Site 000015
Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
PHASE3Open label, prospective, single-center, randomized, two sequence, three per...
Location
University of Illinois, Chicago
Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
PHASE3This is 2-armed parallel group, prospective, randomized, open-label, multic...
Location
California Institute of Renal Research/ Sharp Memorial
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
PHASE3The overall aim of the study is to prospectively investigate the impact of ...
Location
Northwestern University
Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients
PHASE2The purpose of this study is to demonstrate the pharmacokinetics (PK, measu...
Location
LifeLink Healthcare Institute
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
PHASE2The purpose of this study is to demonstrate the pharmacokinetics (PK, measu...
Location
University of Cincinnati